CPT1A and fatty liver disease: Although some reports suggest that TH increases the activity of hepatic lipases, lipophagy, and β-oxidation of fatty acids, which help fatty liver to reduce steatosis (2, 46–48), little changes were found here in genes involved in fat oxidation (CPT1a, CD36, and AOX) (Fig. S17).